TIS tissue therapies limited

Accident prone

  1. 347 Posts.
    How can any investor, including institutional investors, have any confidence in Mercer and his team now ?

    They've had months and months to get their house in order and still this happens, and it is conveyed to the market with one paragraph. They "had a commitment" from the EMA that there would be NO FURTHER delays or deferrals. What is going on?

    I suspect that the EMA told them behind the scenes that there was something still outstanding and needed to be included so TIS have been given a bit more time.

    Whatever the case, this company's management are accident prone and I can't see them bumbling and bumping along any better if VitroGro ever goes to market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.